ArticleBiomedicines2023

DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer.

Carlos Lacalle-Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.